SMYD3 is a methyltransferase highly expressed in many types of cancer. It usually functions as an oncogenic protein to promote cell cycle, cell proliferation, and metastasis. Here, we show that SMYD3 modulates another hallmark of cancer, DNA repair, by stimulating transcription of genes involved in multiple steps of homologous recombination. Deficiency of SMYD3 induces DNA-damage hypersensitivity, decreases levels of repair foci, and leads to impairment of homologous recombination. Moreover, the regulation of homologous recombination-related genes is via the methylation of H3K4 at the target gene promoters. These data imply that, besides its reported oncogenic abilities, SMYD3 may maintain genome integrity by ensuring expression levels of HR proteins to cope with the high demand of restart of stalled replication forks in cancers.
expression 31 . Moreover, SMYD3 modifies non-histone proteins VEGFR and MAP3K2 to promote metastasis 32 and Ras/Raf/MEK/ERK signaling 33 in cancer development, respectively.
Previous studies have focused on the ability of how SMYD3 stimulates cell proliferation and metastasis. Here, we identify a new role of SMYD3 in regulating HR repair. Inhibition of SMYD3 directly blunts HR efficiency by downregulating the expression of HR-related genes. Additionally, SMYD3 knockdown leads to decreased methylation of H3K4 and recruitment of RNA polymerase II (RNAPII) at the target gene promoters. These data reveal that SMYD3 maintains genome stability by ensuring normal expression levels of HR repair proteins.
Results
Microarray data analysis identifies SMYD3-regulated expression of DNA repair machinery. Increased expression of SMYD3 can promote cancer proliferation 24 and metastasis 30 . To explore additional and novel roles of SMYD3 in biological processes, we analysed our previously conducted whole-genome microarray data of RNAs isolated from shLuc vs. shSMYD3 MCF7 cells (GEO accession number GSE58048), in which a lentivirus shRNA infection system was used for stable knockdown of SMYD3 26 . 449 genes were downregulated upon SMYD3 knockdown. The gene ontology (GO) analysis indicated that these genes were mainly involved in cell cycle, DNA metabolic process, response to DNA damage stimulus, cell proliferation and macromolecular complex subunit organization (Fig. 1a ). Previous reports provided evidence that SMYD3-dependent histone methylations are essential for cell cycle and cell proliferation. Intriguingly, SMYD3 is associated with DNA damage response (DDR) in the top three categories of GO analysis. Since SMYD3 has not been linked to DDR or DNA repair, the mechanism was further analysed.
We first investigated whether SMYD3 knockdown cells are more vulnerable to DNA damage stress such as IR. To examine the repair rate following IR, the formation of γH2A.X foci were used as a marker for DNA damage. Following exposure to 1.67 Gy of IR, SMYD3 knockdown cells significantly delayed the removal of γH2A.X foci at 48 and 72 hr compared to the shLuc controls ( Fig. 1b) . Conversely, exogenous expression of SMYD3, but not the catalytic dead mutant SMYD3 Y239F proteins, in the SMYD3 knockdown cells significantly restored the defects at 24 and 72 hr compared to that in the shSMYD3 with the expression of the vector control ( Fig. 1c ). The clonogenic survival following exposure to IR was further examined, and knockdown of SMYD3 led to impeded formation of colonies ( Fig. 1d ). Similar to that in MCF7 cells, shSMYD3 MDA-MB-231 and AU565 cells were more vulnerable to IR stress ( Fig. 1e,f) .
We next analysed the effect of IR on SMYD3's cellular location. The majority of SMYD3 is located in the cytoplasm 33 , and we wondered whether it would translocate into the nucleus upon DNA damage insults. Cells were exposed to increasing dosages of IR and assayed for the translocation of SMYD3 protein to the nucleus at 1 and 3 hours. The distribution of SMYD3 did not show any noticeable difference after IR treatment ( Supplementary  Fig. S1a ). Furthermore, the gene and protein expression of SMYD3 were not augmented after IR treatment ( Supplementary Fig. S1b ). These results suggest that DNA damage does not modulate SMYD3 expression and location.
We further examined whether SMYD3 affects genome integrity in cells. To determine if the loss of SMYD3 is associated with increased DNA damage, we performed a single-cell gel electrophoresis (comet) assay. The comet assay revealed increases of damage rate and tail moment in shSMYD3 compared to those in shLuc cells at 72 h ( Fig. 2a -c). We also investigated micronuclei formation, a well-established indicator for genome instability 34, 35 , which occurs through the aberrant segregation of chromosomes or acentric chromosomal fragments. Compared to the shLuc control, knockdown of SMYD3 caused an increase in IR-induced micronuclei at 72 h ( Fig. 2d ). Taken together, these data suggest a role of SMYD3 in DNA repair mechanism. SMYD3 mediates the HR pathway. Since mammalian DSB repair was achieved mainly by two mechanisms, HR and NHEJ, we wondered whether SMYD3 is involved in these pathways. We used cells with well-characterized GFP-based chromosomal reporters to detect the efficiency of HR. The reporter contains an I-SceI recognition sequence, which would be cleaved upon I-SceI expression to generate a DSB. DSB repair by HR using the direct repeat within the reporter cassette as a template results in an intact GFP gene. The repair efficiency was then quantified by flow cytometry. For the plasmid-based end-joining assay, a linearized plasmid harboring a luciferase reporter gene was used. Repair efficiency was measured by the luciferase activities of linearized reporter constructs compared with that of the intact plasmid. Results demonstrated that SMYD3 knockdown significantly hampered HR repair by 55-70% compared to the control cells ( Fig. 3a) . In contrast, SMYD3 knockdown did not change the NHEJ activity compared to the control cells ( Fig. 3b ). As the controls for the HR and NHEJ assays, knockdown of EXO1 reduced the HR activity and knockdown of Ku70 impaired the NHEJ activity by 56-73% and 47-50%, respectively ( Fig. 3a,b ). We also examined whether SMYD3 was required by MMEJ using a plasmid-based MMEJ assay and found that SMYD3 did not display any effect on the efficiency of MMEJ, while knockdown of the control, POLQ, reduced MMEJ activity by 49-58% (Fig. 3c ). The knockdown effectiveness of each cell lines used was confirmed by qRT-PCR ( Supplementary Fig. S2a-c) . Moreover, the exogenous expression of SMYD3, but not the SMYD3 Y239F proteins ( Supplementary Fig. S2d ), restored the HR activity of the shSMYD3 cells ( Fig. 3d) . These results identify a role of SMYD3 in HR repair.
SMYD3 knockdown downregulates HR gene expressions. To understand the exact role of SMYD3
in HR repair, we analysed microarray-identified genes that were related to DDR and found that 25 of them are involved in DNA repair. Among these 25 genes, 13 genes are implicated in the HR pathway (Table 1 ). These genes range from the early step of DNA damage mediators, kinase transducer to downstream effectors that execute error-free repair process 36 . We performed qRT-PCR analysis to confirm their expressions and found that all genes exhibited similar fold differences in mRNA expression as initially identified in the microarray analysis ( Fig. 4a ). Among these genes, MDC1 plays the earliest role in HR repair 37 and participates in the initial recruitment of BRCA1 [38] [39] [40] [41] [42] to promote DNA end resection for HR 43 . Moreover, EXO1 is the major exonuclease for efficient end resection 4 , and RAD54B is a DNA-dependent ATPase required for efficient chromatin remodeling during strand invasion 7, 8 . We checked the influence of SMYD3 depletion on MDC1, EXO1, and RAD54B. Consistently, the protein levels of MDC1 and EXO1 were significantly reduced after inhibition of SMYD3. Besides, a marginal reduction of the RAD54B protein was observed ( Fig. 4b ).
To gain further insight into how SMYD3 regulates HR activity, we investigated the significance of SMYD3 on the formation of MDC1 foci. After IR treatment, MDC1 foci were diminished in SMYD3-depleted cells at 1 to 4 hrs ( Fig. 4c ). And these MDC1 foci were disappeared at 24 to 72 hrs, even in the shLuc cells ( Supplementary  Fig. S3a ). Moreover, after IR treatment, the formation of BRCA1 foci in SMYD3 knockdown cells was impaired as well ( Fig. 4d and Supplementary Fig. S3b ). In contrast, lack of SMYD3 did not affect the assembly of 53BP1 foci ( Supplementary Fig. S3c ). These data indicated that SMYD3 deficiency weakens HR partly through downregulation of MDC1, thereby compromising the recruitment of BRCA1 at DSBs.
SMYD3 controls the expression of HR genes through methylating histone H3K4. SMYD3 was
initially reported to methylate histone H3K4 to modulate the accessibility of chromatin architecture and to form a complex with RNA polymerase II (RNAPII) and RNA helicase HELZ to drive its target genes 24 . To explore the epigenetic regulation of SMYD3 on these HR genes, we examined the recruitments of SMYD3, H3K4me3, and RNAPII pSer5, which is a required RNAPII phosphorylation for the transcriptional initiation 44 , to the MDC1, EXO1, and RAD54B promoter regions. The putative TATA box (region TA) was retrieved from GPMiner 45 . ChIP experiments showed a direct binding of SMYD3 to the MDC1 promoter (region S3) at ~500 bp upstream of the transcription start site (TSS) (Fig. 5a ). SMYD3 preferred to enrich at region S3 (blue bar) than region TA (red bar) ( Fig. 5b) . In contrast, RNAPII pSer5 ( Fig. 5c ) and histone H3K4me3 (Fig. 5d ) exhibited greater binding at region TA than region S3. Furthermore, knockdown of SMYD3 led to significant decreases of SMYD3, H3K4me3, H3 and RNAPII pSer5 at various degrees at both regions S3 and TA ( Fig. 5b-e ). Also, the enrichment of H3K4me3-modified histones (H3K4me3/H3) declined significantly in SMYD3 knockdown cells ( Fig. 5f ). A similar tendency was observed in the promoter regions of EXO1 and RAD54B ( Supplementary Fig. S4 ). These results suggest that SMYD3 may trigger HR gene expression by directly binding to the promoters to create an active histone mark for transcription. 
Discussion
SMYD3 is a transcriptional regulator that functions, in part, through histone methylation to control the expression of target genes. Apart from previously identified targets WNT10B 25 , hTERT 31 , CCNA1 26 , NKX2.8 24 , MMP9 46 , and c-MET 47 , we show here that SMYD3 facilitates expression of several genes involved in the whole process of HR repair. Deficiency of SMYD3 hampers the expression of these HR associated genes, induces DNA-damage hypersensitivity, causes genomic instability, decreases the levels of MDC1 and BRCA1 foci, and leads to impairment of HR-mediated DSB repair. Furthermore, generation of the active transcription mark H3K4me3 and phosphorylation of RNAPII C-terminus Ser5 at the MDC1, EXO1, and RAD54B promoters are SMYD3-dependent. These findings provide insights into how SMYD3 functions as an oncogene besides its abilities in promoting cell cycle, cell proliferation, and metastasis. The newly identified role of SMYD3 in HR repair proves that SMYD3's function is crucial in maintaining genome stability (Fig. 6 ). Consistent with recent reports, highly proliferative cells, such as cancer cells, rely profoundly on HR-mediated DSB repair to restart the stalled replication forks at S phase 48, 49 . The activity of SMYD3 is closely related to the cell cycle progression 26, 50 . Deficiency of SMYD3 leads to G1-phase cell cycle arrest in breast cancer cells 30, 50 and S-phase arrest in prostate cancer cells 51 . Therefore, it is likely that slower removal of IR-induced γH2A.X foci (Fig. 1b ) might also be contributed partly from the impact of SMYD3 on cell cycle. Notably, SMYD3 deficient cells could proceed the cell cycle to finish mitosis, but generate more micronuclei which represent aberrant chromosomal segregation (Fig. 2d ). The combinational effects of genomic instability and the lack of proper DNA repair machinery in SMYD3-depleted cells may therefore lead to apoptosis 50, 51 .
Large-scale screens have revealed a correlation between SMYD3 and DNA repair pathways. Knockdown of SMYD3 caused differentially expressed DNA repair genes RAD50 and RAD51 in prostate cancer cells 52 . A proteomic analysis discovered that SMYD families share some common interactors (NPM1, TOP1, GNL3, and RUVBL2) involved in DNA repair and chromatin maintenance 53 , which may imply that SMYD3 not only modulates the DNA repair pathways at the transcription level but also directly interacts with DDR proteins. Moreover, mono-methylation of poly(ADP-ribose) polymerase-1 (PARP1) by SMYD2, another SMYD family methyltransferase, enhances PARP1 activity and cellular response to oxidative DNA damage 54 . Therefore, we propose that SMYD3 may regulate DNA repair at both transcriptional and posttranscriptional levels.
Most histone methylation occurs at specific sites of H3 and H4, which is controlled by a large group of methyltransferases and demethylases. For example, SETD2-dependent H3K36me3 is essential for efficient end resection of HR through the recruitment of CtIP, RPA, and RAD51 55, 56 . Interestingly, the levels of SETD2 and H3K36me3 are not induced after DSB damage, suggesting their pre-established role on chromatin 56, 57 . Similarly, the distribution and protein amount of SMYD3 are not adjusted after IR treatment ( Supplementary Fig. S1 ). These finding may imply that the amount of nuclear SMYD3 is sufficient for driving HR gene expression and that these HR proteins are constitutively expressed for taking care of sudden DNA damage. The property that SMYD3 is preferentially recruited to individual promoters may rely on both its binding sequences and its binding partners. Further investigation is required to clarify this specificity.
Methods

Cell lines, plasmids, and transfection. The breast cancer cell lines MCF7, MDA-MB-231 and AU565
were maintained in their respective media according to ATCC protocols. HEK293T cells were co-transfected with packaging plasmid (pCMV-Δ8.91), envelope (pMDG), and hairpin pLKO-RNAi vectors (National RNAi Core Facility, Institute of Molecular Biology/Genomic Research Centre, Academia Sinica, Taiwan) for virus packaging. The specific oligo sequences of shRNA are listed in Supplementary Table S1 . Virus-containing supernatants were collected at 48 hr post-transfection. Cells were treated with virus plus medium containing polybrene (8 μg/ml) for 16 hr. The infected cells were selected with puromycin (1 μg/ml). Plasmids expressing SMYD3 WT and methyltransferase-dead SMYD3 Y239F were constructed as previously described 26 .
Data analysis of gene expression microarray. The microarray analysis of shLuc vs. shSMYD3
viruses-treated MCF7 cells was performed as previously described with the NCBI Gene Expression Omnibus (GEO) accession number GSE58048 26 . The list of down-regulated genes was further categorized by the DAVID v6.8 Gene Ontology program 58, 59 .
Cell fixation and immunofluorescence assays. Cells were seeded on glass coverslips coated with poly-L-lysine (Sigma-Aldrich, St. Louis, MO, USA) and allowed to attach for 48 hr followed by 1.67 Gy IR treatment (IBL 637, CIS Bio International, Gif-sur-Yvette, France). After washed with phosphate buffered saline (PBS), cells were fixed in 4% paraformaldehyde in PBS for 10 min at room temperature. The fixed cells were then permeabilized with 0.1% Triton X-100 in PBS for 10 min. After 30 min of blocking with 1% BSA in PBS, cells were washed in PBS and incubated with primary antibodies for 3 hr. After three times washed in PBS containing 0.05% Triton-X for 5 min, the cells were incubated with secondary antibodies for 1 hr. Finally, cells were washed three times with PBS containing 0.05% Triton-X and embedded in 1 μg/ml DAPI (Sigma-Aldrich) containing mounting solution on glass slides. The cells were visualised with an Olympus fluorescence microscope. Images were captured using a Spot advanced imaging system. The primary antibodies used were γH2A.X (05-636, Millipore-Upstate, Temecula, CA, USA), BRCA1 (sc-6954, Santa Cruz Biotechnology, CA, USA), 53BP1 (sc-22760, Santa Cruz Biotechnology) and MDC1 (A300-053A, Bethyl Laboratories, Montgomery, TX, USA). Colony formation assay. For the colony formation assay, control (shLuc) or knockdown (shSMYD3) cells were seeded (5,000 cells for shLuc cells, and 20,000 and 10,000 cells for shSMYD3#1 and shSMYD3#2 cells, respectively) in 6-cm dishes two days before IR (0, 1.67, 3.34, 5.01 Gy) treatment. Cells were incubated for 15 days, fixed in 4% paraformaldehyde for 5 min, washed once with PBS, stained with 0.1% crystal violet, and then washed with distilled water. The survival rate was calculated by comparing the colonies numbers with the non-irradiated cells in each group.
Nuclear/cytosol fractionation. Approximate 1 × 10 6 MCF7 cells were trypsinized and washed with ice-cold PBS twice followed by lysed on ice for 10 min in 250 μl cytoplasmic lysis buffer (0.1% Triton-X, 10 mM HEPES-KOH pH 7.9, 10 mM KCl, 1.5 mM MgCl 2 , 0.34 M sucrose, 10% glycerol) containing protease inhibitor, 1 mM DTT, and 10 mM PMSF. Nuclear sediments were collected by centrifugation at 6,000 rpm for 1 min, and pellets were washed twice with 1 ml cytoplasmic lysis buffer. Nuclei were lysed in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 1% sodium dodecyl sulfate (SDS), 1 mM DTT, protease inhibitor, 1 mM PMSF, 1 mM EDTA) and lysed completely by sonication. Nuclei and cytosolic extracts were then subjected to Western blot analysis.
Western blot analysis. Western blot analysis was performed as described 26 . The primary antibodies used were SMYD3 (GTX121945, Genetex, San Antonio, TX, USA), MDC1 (GTX102673, GeneTex), EXO1 (GTX109891, GeneTex), RAD54B (GTX103291, GeneTex), Tubulin (GTX112141, GeneTex), and nuclear matrix protein p84 (NB100-174, Novus, Littleton, CO, USA). The quantification of protein expression was performed using ImageJ software (Image Processing and Analysis in Java). All protein expression levels were normalized against the corresponding control protein levels as indicated. Images were representatives of n ≥ 3 for each experiment.
Comet assay. DNA strand breaks were evaluated using alkaline single cell gel electrophoresis (comet) assay following the procedure of Olive and Banath 60 . The quantification of tail moment, a representation of the fluorescence intensity in the tail relative to the head, was performed using CometScore (Autocomet.com), with at least 100 individual cells were analysed per condition.
Micronuclei counts. For micronuclei analysis 34, 35 , cells were seeded and fixed as described in the immunofluorescence assays. The cells were then incubated with SYBR gold (Thermo Fisher Scientific Inc., Waltham, MA, Figure 6 . SMYD3 methylates histone and non-histone substrates to regulate different pathways that are important for hallmarks of cancer. SMYD3 directly methylates proteins that are involved in cell proliferation and angiogenesis. Moreover, SMYD3 methylates histones that are widely spread on chromatin to facilitate transcription of target genes. Hence, the high level of SMYD3 stimulates cancer development.
Scientific RepoRts | 7: 3842 | DOI:10.1038/s41598-017-03385-6 USA) for 1 min, washed twice with PBS, and mounted for microscopy. Objects were defined as micronuclei if they were clearly separated from the nuclei, were round-to oval-shaped with distinct borders, had an area of less than a quarter of the area of a nucleus, and showed staining characteristics similar to those of nuclei.
RNA analysis and quantitative real-time polymerase chain reaction (qRT-PCR).
Total RNA was isolated using the RNeasy kit (Qiagen, Valencia, CA, USA). RNA was reverse-transcribed into first-strand cDNA using AMV reverse transcriptase (Promega, Madison, WI, USA). cDNA was amplified with KAPA SYBR Fast PCR Mix (KAPA Biosystems, Woburn, MA, USA) and subjected to analysis using a CFX Connect Real-Time System thermal cycler (Bio-Rad, Hercules, CA, USA). RPL30 mRNA, which encodes the ribosomal protein L30, was used as an internal control. The relative abundance of mRNA was calculated after normalization with RPL30 mRNA using the CT equation. For verifying candidate genes in microarray data, primers were either designed based on the coding sequence of each genes using Primer3Plus 61 or directly retrieved from Origene website (http://www.origene.com/). The primers used are listed in Supplementary Table S2. HR assay. HR efficiency was measured in MCF7/DR-GFP cells, according to the previous report 62 . The MCF7 DR-GFP cells harbor GFP-based chromosomal reporters. The stable cells possess two differential GFP mutant genes oriented as direct repeats and separated by a drug selection marker, the puromycin N-acetyltransferase gene. Transient expression of the I-SceI enzyme produces a DSB in one of the two GFP mutant genes. The DSB can be repaired by HR between the two GFP mutant genes, resulting in the restoration of a functional GFP gene and the expression of GFP proteins. After knockdown of target genes for three days, cells were transfected with pCASce to express the I-SceI protein. GFP-positive cells were measured by flow cytometry (BD FACSCalibur, BD Biosciences, Miami, FL, USA) in 48 hr. Ds-Red was transfected in a parallel group as a control for transfection efficiency.
Plasmid based end-joining assay. Plasmid end-joining assay was conducted as previously described 63 .
The pGL3-promoter plasmid (Promega), which harbors a luciferase reporter gene, was linearized by HindIII and confirmed by agarose gel electrophoresis. The linearized DNA was purified by gel extraction kit (Qiagen), dissolved in sterilized water, and transfected into cells after knockdown of target genes for three days. Luciferase protein was expressed when the cutting sites were repaired by end-joining. The luciferase activity was assayed by Luciferase Assay System (Promega). A Renilla plasmid was co-transfected as a control.
Plasmid based MMEJ assay. MMEJ efficiency was measured according to the previous report 64 . The pSV40-MMEJ plasmid, which harbors a GFP reporter gene, was a gift from Dr. Nicolas Mermod. Plasmids were linearized by I-SceI, purified by gel extraction kit (Qiagen), and transfected into cells after knockdown of target genes for three days. GFP protein was expressed when the cutting sites were repaired by MMEJ. The pGK-GFP plasmid was transfected in parallel as a transfection efficiency control. Expression of GFP was measured by flow cytometry (FACSCalibur, BD BioSciences) after 48 hr of transfection.
ChIP assay. ChIP assays were performed as described 26 . Complexes were immunoprecipitated overnight with 2 μg of antibodies specific for SMYD3 (GTX121945, GeneTex), rabbit IgG (GTX35035, GeneTex), H3 (ab1791, Abcam, Cambridge, MA, USA), H3K4me3 (ab10158, Abcam), and RNA polymerase II CTD repeat YSPTSPS (phosphor Ser5) (ab5131, Abcam). Input samples were processed in parallel. Antibody/protein complexes were collected by 40 μl of protein G-coupled Sepharose beads (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA) and washed as follows: once with Tris/EDTA-150 mM NaCl, twice with Tris/EDTA-500 mM NaCl, and once with PBS. Immune complexes were eluted with 1% SDS and TE buffer. After decrosslinking, DNA was purified using a PCR cleanup kit (Qiagen) and analysed by qRT-PCR. The results were expressed as the percentage of the initial inputs. The primer sets used for the ChIP assay are listed in Supplementary Table S2 .
Statistical analysis. Each experiment was repeated at least three times with comparable results. Results are expressed as mean ± SD. All statistical analyses were performed using Excel 2010 (Microsoft; Redmond, WA). The p-values for all experiments were obtained using two-tailed Student's t tests to evaluate differences between two groups, with P < 0.05 considered statistically significant.
